-
Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. The Scripps Research Institute, La Jolla, Calif. Business: Infectious Johnson & Johnson's Janssen Pharmaceuticals Inc. unit partnered with the institute under a five-…
Published on 5/13/2013
-
Kinex Pharmaceuticals LLC, Buffalo, N.Y. Zenith Technology Corp., location undisclosed Business: Cancer, Drug delivery Kinex granted Zenith marketing rights to cancer candidates Oraxol and Oratecan in Australia and New …
Published on 5/13/2013
-
Ligand Pharmaceuticals Inc. (NASDAQ:LGND), La Jolla, Calif. Selexis S.A., Geneva, Switzerland Business: Biomanufacturing Ligand acquired from Selexis a portfolio of potential milestone and royalty payments for more than…
Published on 5/13/2013
-
MorphoSys AG (Xetra:MOR; Pink:MPSYF), Martinsried, Germany Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Ophthalmic MorphoSys received an undisclosed milestone payment from Novartis under a 2007 deal …
Published on 5/13/2013
-
Nimbus Discovery LLC, Cambridge, Mass. Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Business: Endocrine/Metabolic Nimbus and Shire partnered to discover and develop oral small molecules against an undisclosed …
Published on 5/13/2013
-
Ocera Therapeutics Inc., San Diego, Calif. Tranzyme Inc. (NASDAQ:TZYM), Durham, N.C. Business: Hepatic Tranzyme and Ocera said that Ocera will merge with Tranzyme's Terrapin Acquisition Inc. subsidiary in a stock deal …
Published on 5/13/2013
-
Oncobiologics Inc., Cranbury, N.J. Zhejiang Huahai Pharmaceutical Co. Ltd. (Shanghai:600521), Zhejiang, China Business: Biosimilars Oncobiologics and Huahai partnered to co-develop and commercialize four biosimilars. …
Published on 5/13/2013
-
Oxford BioMedica plc (LSE:OXB), Oxford, U.K. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Drug delivery, Gene/Cell therapy Oxford BioMedica will use its LentiVector gene delivery technology to …
Published on 5/13/2013
-
Pharmascience Inc., Montreal, Quebec Redx Pharma Ltd., Liverpool, U.K. Business: Cancer Pharmascience granted Redx rights to develop and commercialize Pharmascience's small molecule inhibitors of colony-stimulating …
Published on 5/13/2013
-
Protein Sciences Corp., Meriden, Conn. Business: Infectious Protein Sciences said it completed development of a vector required to manufacture a vaccine against the new H7N9 avian influenza virus circulating in China. …
Published on 5/13/2013
-
Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Novato, Calif. Aix-Marseille University, Marseille, France French National Institute of Health and Medical Research (INSERM), Paris, France Institut Curie, Paris, France …
Published on 5/13/2013
-
Sagent Pharmaceuticals Inc. (NASDAQ:SGNT), Schaumburg, Ill. Chengdu Kanghong Pharmaceuticals Co. Ltd., Chengdu, China Business: Drug delivery Sagent will acquire Chengdu Kanghong's 50% stake in the companies' 50/50 JV …
Published on 5/13/2013
-
Sanofi (Euronext:SAN; NYSE:SNY), Paris, France ChemRar Ventures, Khimki, Russia Business: Pharmaceuticals The companies signed an 18-month scouting agreement for venture investment in Russia and Asia under which ChemRar…
Published on 5/13/2013
-
Trevena Inc., King of Prussia, Pa. Forest Laboratories Inc. (NYSE:FRX), New York, N.Y. Business: Cardiovascular Trevena granted Forest an exclusive option to license worldwide development and commercialization rights to…
Published on 5/13/2013
-
Warner Chilcott plc (NASDAQ:WCRX), Dublin, Ireland Actavis Inc. (NYSE:ACT), Parsippany, N.J. Business: Generics, Pharmaceuticals Generics company Actavis and specialty pharma Warner Chilcott announced they are in "early…
Published on 5/13/2013
-
AbCheck s.r.o., Plzen, Czech Republic Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Business: Antibodies, Cancer AbCheck will use its AbSieve phage and yeast display technologies to discover antibodies …
Published on 2/25/2013
-
Advanced Cell Technology Inc. (OTCBB:ACTC), Santa Monica, Calif. International Stem Cell Corp. (OTCBB:ISCO), Carlsbad, Calif. Business: Cell/Gene therapy Advanced Cell and International Stem Cell amended a 2004 deal to …
Published on 2/25/2013
-
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Cheshire, Conn. Business: Hematology Alexion recommended shareholders reject an unsolicited mini-tender offer by investment firm TRC Capital Corp. to acquire up to 1.5 million…
Published on 2/25/2013
-
Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Selexis S.A., Geneva, Switzerland Business: Biomanufacturing The companies expanded a 2004 R&D license to grant Amgen non-exclusive rights to use Selexis' SURE CHO-M cell …
Published on 2/25/2013
-
Andrus Reo Ltd., Moscow, Russia Oncolytics Biotech Inc. (TSX:ONC; NASDAQ:ONCY), Calgary, Alberta Business: Cancer Oncolytics granted Andrus Reo rights in Russia and the Commonwealth of Independent States (CIS) to …
Published on 2/25/2013
-
AquaBounty Technologies Inc. (LSE:ABTX), Maynard, Mass. Intrexon Corp., Blacksburg, Va. Business: Agbio/Environmental Intrexon and aquaculture company AquaBounty partnered to use Intrexon's UltraVector synthetic biology…
Published on 2/25/2013
-
Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Samsung Group, Seoul, South Korea Business: Biosimilars Merck partnered with Samsung Bioepis Co. Ltd. to develop and …
Published on 2/25/2013
-
Biomedical Structures LLC, Warwick, R.I. TissueGen Inc., Dallas, Texas Business: Drug delivery The companies partnered to develop a finished textile platform for drug-eluting medical devices using TissueGen's fiber-…
Published on 2/25/2013
-
BioNTech AG, Mainz, Germany 4SC AG (Xetra:VSC), Planegg-Martinsried, Germany Business: Cancer 4SC's 4SC Discovery GmbH subsidiary will identify and optimize small molecule anti-cancer drugs against undisclosed targets …
Published on 2/25/2013
-
Caliber Biotherapeutics LLC, Bryan, Texas iBio Inc. (NYSE-M:IBIO), Newark, Del. Business: Cancer, Biomanufacturing iBio granted Caliber a non-exclusive license to use iBio's iBioLaunch plant-based vaccine and …
Published on 2/25/2013